Oregon Compounding Centers, Inc. dba Creative Compounds recalls ESTRADIOL CYPIONATE (COMPOUNDED/GRAPESEED OIL), 5 mg/mL, injectable, 1 ml glass vial, RX, Creative Compounds, Wilsonvill
Recalled November 12, 2014 · FDA recall D-0189-2015 · Oregon Compounding Centers, Inc.
Hazard
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. · FDA Class II
Units
4 mL
Sold at
Oregon, Washington
Description
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product
ESTRADIOL CYPIONATE (COMPOUNDED/GRAPESEED OIL), 5 mg/mL, injectable, 1 ml glass vial, RX, Creative Compounds, Wilsonville, OR 97070
Manufacturer(s)
Oregon Compounding Centers, Inc. dba Creative Compounds
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →